NicOx

Healthcare 📍 Valbonne, France 👥 51-200 employees 💰 $149.0M raised 📅 Founded 1996

NicOx S.A., a biopharmaceutical company, engages in the development and commercialization of nitric oxide (NO)-donating drugs primarily for inflammation and cardio-metabolic diseases. The company's primary products candidates include Naproxcinod, a Phase III product candidate for the treatment of osteoarthritis; and NC

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

France

Employees

51-200

Total Raised · Post-IPO

$149.0M

Founded

1996

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$450K – $1M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	Google Analytics
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from NicOx's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction